Search | New Scientist

New breast cancer gene tests will mean hard choices for many women

12 September 2018

We are starting to learn more about how gene variants influence the risk of getting breast cancer, but deciding how to use the results raises ethical dilemmas

There is no evidence that the weedkiller glyphosate causes cancer

14 August 2018

Agrichemical firm Monsanto has been ordered to pay $289 million to a man who says its products caused his cancer – but scientific evidence for links to cancer is lacking

So-called ‘holy grail’ cancer test would miss thousands of cases

1 June 2018

Newspaper reports have hailed a blood test for detecting several types of cancer as the “holy grail of cancer research”, but it is far from accurate enough

How Theresa May’s plan for an AI-powered NHS could go very wrong

21 May 2018

Trials of artificial intelligence show it can spot diseases that doctors miss – but rolling the tech out across the UK might prove more difficult

23andMe's breast cancer test may create false sense of security

7 March 2018

Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?

Calm down – China is not racing ahead with human CRISPR trials

25 January 2018

Despite treating 86 people since 2015, China's approach to CRISPR genome-editing in humans is basic and risky

Ban on weedkiller glyphosate won't save anyone from cancer

26 October 2017

Unfounded health fears mean Europe is on the brink of banning the herbicide, risking greater soil damage and higher carbon emissions

Refusing boys HPV vaccine saves the NHS cash but is bad science

20 July 2017

A UK advisory committee has decided that it isn’t cost effective to give boys a vaccine that wards off cancer, but that ignores the reality of teenagers’ sex lives